Search Within

Margaret Kathleen Callahan

Formats
  1. Journal Article (105)
  2. Meeting Abstract (84)
  3. Editorial (4)
  4. Book Section (2)
  5. Research Letter (2)
  6. Guidelines (1)
  7. Review (1)
Groups
  1. Department of Medicine (199)
  2. Melanoma and Immunotherapeutics Service (199)
  3. Solid Tumor Oncology Division (199)
  4. GSK Faculty (123)
  5. Melanoma Disease Management Team (108)
  6. Hematologic Malignancies, Division of (77)

More Groups

People
  1. Jedd Wolchok (113)
  2. Michael Postow (96)
  3. Paul Chapman (50)
  4. Alexander Shoushtari (46)
  5. Katherine Panageas (38)
  6. Parisa Momtaz (30)

More People

Years
  1. 2025 (5)
  2. 2024 (6)
  3. 2023 (9)
  4. 2022 (13)
  5. 2021 (11)
  6. 2020 (19)

More Years

Publications
  1. Journal of Clinical Oncology (61)
  2. Journal for ImmunoTherapy of Cancer (17)
  3. Science Translational Medicine (10)
  4. Annals of Oncology (7)
  5. Clinical Cancer Research (7)
  6. New England Journal of Medicine (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (65)
  2. Biomed Central Ltd (17)
  3. American Association for Cancer Research (15)
  4. Elsevier Inc. (15)
  5. Oxford University Press (15)
  6. Nature Publishing Group (11)

More Publishers

Results (199)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neurotoxicity in patients with metastatic solid tumors treated with immune checkpoint inhibitors: A single institution retrospective analysis
    Meeting Abstract

    Santomasso, B.; Malani, R.; Haggiagi, A.; Holder, J.; Shames, Y.; Briggs, S.; Callahan, M.
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • The development of neurologic immune related adverse events (irAEs) in patients with metastatic solid tumors treated with immune checkpoint inhibitors: A single institution retrospective analysis
    Meeting Abstract

    Malani, R.; Haggiagi, A.; Holder, J.; Shames, Y.; Briggs, S.; Santomasso, B.; Callahan, M.
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • The development of brain metastasis in the patients with metastatic non-small cell lung cancer (NSCLC) and melanoma treated with immune checkpoint inhibitors: A retrospective analysis
    Meeting Abstract

    Chaul-Barbosa, C.; Niotis, K.; Hellmann, M.; Callahan, M.; Daras, M.
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Lesion response and intracranial control of brain metastases from non-small cell lung cancer after stereotactic radiosurgery or hypofractionated radiation therapy combined with checkpoint inhibitors
    Meeting Abstract

    Imber, B. S.; Hellmann, M. D.; Kris, M. G.; Santomasso, B. D.; Callahan, M. K.; Osorio, J.; Rizvi, H.; Chan, T. A.; Yang, T. J.; Yamada, Y.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Initial efficacy of anti-lymphocyte activation gene-3 (anti-LAG-3; BMS-986016) in combination with nivolumab in patients with melanoma who progressed during prior anti-PD-1/PD-L1 therapy
    Meeting Abstract

    Ascierto, P. A.; Melero, I.; Bhatia, S.; Bono, P.; Sanborn, R. E.; Lipson, E. J.; Callahan, M. K.; Gajewski, T.; Gomez-Roca, C. A.; Hodi, F. S.; more...
    Asia-Pacific Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Evaluation of nivolumab (nivo) alone and in combination with ipilimumab (ipi) in patients (pts) with advanced (adv) small-cell lung cancer (SCLC): First report of a randomized expansion cohort from the CheckMate 032 trial
    Meeting Abstract

    Atmaca, A.; Hellmann, M. D.; Ott, P. A.; Zugazagoitia, J.; Ready, N.; Hann, C. L.; De Braud, F.; Antonia, S.; Ascierto, P.; Moreno, V.; more...
    Oncology Research and Treatment (2017)

    Fulltext@MSK | Save
  • Overall survival with combined nivolumab and ipilimumab in advanced melanoma
    Journal Article

    Wolchok, J. D.; Chiarion-Sileni, V.; Gonzalez, R.; Rutkowski, P.; Grob, J. J.; Cowey, C. L.; Lao, C. D.; Wagstaff, J.; Schadendorf, D.; Ferrucci, P. F.; more...
    New England Journal of Medicine (2017)

    Fulltext@MSK | Save
  • Health-related quality of life results from the phase III CheckMate 067 study
    Journal Article

    Schadendorf, D.; Larkin, J.; Wolchok, J.; Hodi, F. S.; Chiarion-Sileni, V.; Gonzalez, R.; Rutkowski, P.; Grob, J. J.; Cowey, C. L.; Lao, C.; more...
    European Journal of Cancer (2017)

    Fulltext@MSK | Save
  • Patient perspectives on ipilimumab across the melanoma treatment trajectory
    Journal Article

    Shuk, E.; Shoushtari, A. N.; Luke, J.; Postow, M. A.; Callahan, M.; Harding, J. J.; Roth, K. G.; Flavin, M.; Granobles, A.; Christian, J.; more...
    Supportive Care in Cancer (2017)

    Fulltext@MSK | Save
  • Thinking critically about classifying adverse events: Incidence of pancreatitis in patients treated with nivolumab + ipilimumab
    Journal Article

    Friedman, C. F.; Clark, V.; Raikhel, A. V.; Barz, T.; Shoushtari, A. N.; Momtaz, P.; Callahan, M. K.; Wolchok, J. D.; Chapman, P. B.; Hellmann, M. D.; more...
    JNCI: Journal of the National Cancer Institute (2017)

    Fulltext@MSK | Save